Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Hawkins Dr
01614 Pfpw
Iowa City, IA 52242Phone+1 319-353-8836Fax+1 319-356-1530- Is this information wrong?
Education & Training
- Cleveland Clinic FoundationResidency, Radiation Oncology, 2003 - 2008
- University of Texas Medical Branch School of MedicineClass of 2003
Certifications & Licensure
- IA State Medical License 2008 - 2025
- OH State Medical License 2003 - 2025
- American Board of Radiology Radiation Oncology
Clinical Trials
- [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers Start of enrollment: 2012 Oct 01
- A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme Start of enrollment: 2013 Apr 01
- Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsThe antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury.Mapuskar, K., Pulliam, C., Tomanek-Chalkley, A., Wen, H., Dayal, S., Sindler, A., Beardsley, R., Kennedy, E., Spitz, D., Rastogi, P., Griffin, B., Zepeda-Orozco, D., A...> ;Redox Biology. 2024 Apr 1
- Avasopasem for the treatment of radiotherapy-induced severe oral mucositis.Stephen T Sonis, Carryn M Anderson> ;Expert Opinion on Investigational Drugs. 2023 Jul 3
- In Reply to Topkan et al.Carryn M Anderson> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Mar 15
- Join now to see all
Press Mentions
- Avasopasem Promising for Severe Oral Mucositis During IMRT for Locally Advanced Head and Neck CancersJune 4th, 2022
- Galera Therapeutics Announces Avasopasem Manganese (GC4419) Maintained Anti-Cancer Benefit of Chemoradiotherapy for Head and Neck Cancer While Substantially Reducing Radiation-Induced Severe Oral MucositisMarch 1st, 2020
- Data from Galera Therapeutics’ 223-Patient Phase 2b Clinical Trial of GC4419 Presented at MASCC/ISOO 2018 Annual MeetingJune 29th, 2018
- Join now to see all
Hospital Affiliations
- University of Iowa Hospitals and ClinicsIowa City, Iowa
- MercyOne Clinton Medical CenterClinton, Iowa
- Southeast Iowa Regional Medical Center, West Burlington CampusWest Burlington, Iowa
- Des Moines VA Medical CenterDes Moines, Iowa
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: